GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » ROE % Adjusted to Book Value

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) ROE % Adjusted to Book Value : 8.21% (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria ROE % Adjusted to Book Value?

GlaxoSmithKline Consumer Nigeria's ROE % for the quarter that ended in Jun. 2023 was 7.88%. GlaxoSmithKline Consumer Nigeria's PB Ratio for the quarter that ended in Jun. 2023 was 0.96. GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was 8.21%.

GlaxoSmithKline Consumer Nigeria ROE % Adjusted to Book Value Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria ROE % Adjusted to Book Value Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.42 12.75 7.57 9.29 10.64

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.49 7.84 8.13 15.91 8.21

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value falls into.


GlaxoSmithKline Consumer Nigeria ROE % Adjusted to Book Value Calculation

GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.19% / 0.77
=10.64%

GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=7.88% / 0.96
=8.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Consumer Nigeria ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
NSA:UBNP NSA:CUSTODIAN NSA:AIIC NSA:FBP NSA:STERLINGNG NSA:MBAS NSA:WEMA NSA:FCMB NSA:JUBR NSA:NSLTECH LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
Website
https://www.ng.gsk.com
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines